Press Coverage

Benefits of Cellvizio in Chronic Digestive Disease

28 April 2017

Robert Danbert, gastroenterologist at San Angelo Community Medical Center, was recognized Thursday as the top U.S. user in 2016 of Cellvizio, an endomicroscopy system that provides physicians with minimally invasive, microscopic images of tissue by generating optical biopsies. Danbert uses Cellvizio as a diagnostic tool for the majority of his gastroenterology cases, most often to monitor patients with gastroesophageal reflux disease (GERD) to determine changes in their esophageal lining, benefiting more than 300 patients in the local area in 2016, according to a news release by The Ruth Group, a health care communications company. GERD is a chronic digestive disease that occurs when stomach acid or, occasionally, stomach content, flows back into the esophagus, irritating the esophagus lining. Both acid reflux and heartburn are common digestive conditions associated with the disease.

Latest News

Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024

Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024

Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances

Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances

Mauna Kea Technologies Reports New Evidence Highly Supportive of the Use of Cellvizio for Diagnosing Pancreatic Cysts Presented at DDW 2024

Mauna Kea Technologies Reports New Evidence Highly Supportive of the Use of Cellvizio for Diagnosing Pancreatic Cysts Presented at DDW 2024